SEGLENTIS

Peak

celecoxib; tramadol hydrochloride

Kowa Pharmaceuticals

NDAORALTABLET

Approved

Oct 2021

Lifecycle

Peak

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Jun 3, 2031

63 months away

Patent Expiry

Jun 3, 2031

Patent Records (5)

Patent #	Expiry	Type	Use Code
11478488	Apr 19, 2030		U-3244
10245276	Apr 19, 2030	SubstanceProduct	—
10548909	Apr 19, 2030		U-3244
10238668	Apr 19, 2030	SubstanceProduct	U-3244
8598152	Apr 19, 2030	SubstanceProduct	—

Company

Kowa Pharmaceuticals

AL - Montgomery

External Resources

Full prescribing information

FDA approval history